Shui He

Shui Shui is an experienced biostatistics professional currently serving as Senior Vice President of Biometrics at Pyxis Oncology since 2021. Previously held the position of Vice President of Biometrics at Replimune in 2021 and Vice President, Head of Global Biometrics at ADC Therapeutics from 2015 to 2021, where notable achievements included building a high-performance team and supporting the company’s IPO and first Biologics License Application. Prior experience includes roles as Associate Director/Director of Biostatistics at Incyte, leading the Jakafi® NDA for Myelofibrosis, and Principal Statistician at Sanofi-aventis, overseeing pediatric sNDA for Taxotere® and other significant drug applications.